Group announces deal to cut price of Cephid's rapid TB test
The deal is expected to make 5 million more tests available, improving access for lower- and middle-income countries.
Stay updated with breaking news from Impact Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The deal is expected to make 5 million more tests available, improving access for lower- and middle-income countries.
The company is seeking the FDA's go-ahead for first-in-human trials in patients with hospital-acquired and ventilator-associated pneumonia.
Since the middle of May, 1,200 child deaths from measles and malnutrition have been reported from war-torn Sudan.
In a population based cohort study, Eveline Klinkenberg and colleagues examine the impact of the PopART intervention on TB prevalence in Zambia and South Africa.
Karume Baderha Augustin Gang’s profile on The Conversation